Cary Street Partners’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.65M Buy
38,549
+5,627
+17% +$595K 0.08% 249
2026
Q1
$3.71M Buy
32,922
+2,353
+8% +$270K 0.09% 223
2025
Q4
$3.37M Buy
30,569
+382
+1% +$43.1K 0.08% 235
2025
Q3
$3.69M Buy
30,187
+246
+0.8% +$31.7K 0.1% 221
2025
Q2
$4.06M Buy
29,941
+3,222
+12% +$435K 0.11% 193
2025
Q1
$3.61M Buy
+26,719
New +$3.53M 0.11% 187

Other funds holding INGR

Cary Street Partners's INGR Position: Q2 2026 in Review

Cary Street Partners increased its Ingredion (INGR) stake by 17% in Q2 2026, buying an estimated $595K and bringing the position to 38,549 shares worth $3.65M. The position accounts for 0.08% of the portfolio, ranked #249.

Cary Street Partners first reported a position in INGR in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.06M in Q2 2025. 613 funds tracked by Wall St. Rank hold INGR as of Q2 2026.

  • Cary Street Partners held 38,549 shares of Ingredion worth $3.65M as of Q2 2026.
  • Cary Street Partners bought 5,627 Ingredion shares in Q2 2026, an estimated $595K.
  • Ingredion made up 0.08% of Cary Street Partners's portfolio in Q2 2026, its #249 holding.
  • Cary Street Partners first reported a position in Ingredion in Q1 2025 and has held it in 6 quarters since.
  • Cary Street Partners's Ingredion position peaked at $4.06M in Q2 2025.
  • 613 funds tracked by Wall St. Rank held Ingredion as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.